Research project
A DAVIES - A Phase 1b/11 combination of ACP-196 with Rituximiab, Cyclophosphamide, doxorubicin, Vincristine and Prenisolone (R-CHOP) for patients with Diffused B-cell Lymphoma (DLBCL) - "ACCEPT" - ACP-196 - ACERTA
-
Research groups:
-
Lead researchers:
-
Research funder:Acerta Pharma BV
-
Status:Not active
